Tower Research Capital (TRC)’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.68K | Sell |
3,252
-286
| -8% | -$412 | ﹤0.01% | 4283 |
|
|
2025
Q1 | $4.6K | Buy |
3,538
+212
| +6% | +$276 | ﹤0.01% | 4233 |
|
|
2024
Q4 | $5.59K | Buy |
3,326
+632
| +23% | +$1.06K | ﹤0.01% | 4269 |
|
|
2024
Q3 | $5.2K | Sell |
2,694
-606
| -18% | -$1.17K | ﹤0.01% | 4311 |
|
|
2024
Q2 | $9.01K | Sell |
3,300
-1,838
| -36% | -$5.02K | ﹤0.01% | 4299 |
|
|
2024
Q1 | $14.7K | Sell |
5,138
-3,964
| -44% | -$11.4K | ﹤0.01% | 3291 |
|
|
2023
Q4 | $22K | Sell |
9,102
-11,749
| -56% | -$28.4K | ﹤0.01% | 3587 |
|
|
2023
Q3 | $63.7K | Buy |
20,851
+14,750
| +242% | +$45.1K | ﹤0.01% | 2345 |
|
|
2023
Q2 | $14.3K | Buy |
6,101
+994
| +19% | +$2.34K | ﹤0.01% | 3685 |
|
|
2023
Q1 | $15K | Buy |
5,107
+1,510
| +42% | +$4.44K | ﹤0.01% | 3759 |
|
|
2022
Q4 | $9K | Sell |
3,597
-3,733
| -51% | -$9.34K | ﹤0.01% | 4156 |
|
|
2022
Q3 | $21K | Buy |
7,330
+189
| +3% | +$541 | ﹤0.01% | 3882 |
|
|
2022
Q2 | $37K | Buy |
7,141
+6,385
| +845% | +$33.1K | ﹤0.01% | 3158 |
|
|
2022
Q1 | $5K | Buy |
+756
| New | +$5K | ﹤0.01% | 5012 |
|
|
2021
Q4 | – | Sell |
-39
| Closed | – | – | 6107 |
|
|
2021
Q3 | $0 | Sell |
39
-119
| -75% | – | ﹤0.01% | 5739 |
|
|
2021
Q2 | $1K | Buy |
+158
| New | +$1K | ﹤0.01% | 5165 |
|